Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Preceptorship on Lung Cancer 2024: Paris

Session 3 – Challenges and Novel Therapies in Clinical Oncology

Participants Clinical Case Discussion: Cytokine Release Syndrome in Lung Cancer Patient Receiving Immune Checkpoint Inhibitors

Date

15 Nov 2024

Session

Session 3 – Challenges and Novel Therapies in Clinical Oncology

Topics

Management of Systemic Therapy Toxicities;  Immunotherapy

Tumour Site

Thoracic Malignancies

Presenters

Ana Geltar, SI

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Standard Second Line Treatments

Presenter: A-M. Dingemans, NL

Session: Session 3 – Challenges and Novel Therapies in Clinical Oncology

Resources:

Slides

Webcast

Antibody-Drug Conjugates

Presenter: D. Planchard, FR

Session: Session 3 – Challenges and Novel Therapies in Clinical Oncology

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.